Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg

DRUG2 trials

Sponsors

George Medicines PTY Limited

Conditions

Hypertension

Phase 3

Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension

CompletedNCT04518306

George Medicines PTY LimitedHypertension

Start: 2021-06-14End: 2023-10-18Updated: 2025-06-03

Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension

CompletedNCT04518293

George Medicines PTY LimitedHypertension

Start: 2021-07-09End: 2023-09-01Updated: 2025-06-03

Related Papers

Long-Term Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination for the Treatment of Hypertension.

2025-10-31

Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trial.

2024-10-0118 citations

Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination Compared With Placebo for Initial Treatment of Hypertension.

2024-08-3119 citations